Shares of 111 Inc – (NASDAQ:YI) traded up 7.1% on Friday . The stock traded as high as $6.06 and last traded at $6.03, 147,760 shares traded hands during trading. An increase of 0% from the average session volume of 147,586 shares. The stock had previously closed at $5.63.

Several research analysts have weighed in on the company. BidaskClub cut 111 from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. ValuEngine upgraded 111 from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 1st.

The stock has a market cap of $491.71 million, a P/E ratio of -7.18 and a beta of 3.15. The firm has a 50-day simple moving average of $6.29 and a two-hundred day simple moving average of $4.84.

111 (NASDAQ:YI) last posted its quarterly earnings data on Thursday, November 14th. The company reported ($0.22) earnings per share for the quarter. The firm had revenue of $155.36 million for the quarter. 111 had a negative return on equity of 42.41% and a negative net margin of 14.86%.

An institutional investor recently raised its position in 111 stock. Tower Research Capital LLC TRC lifted its stake in shares of 111 Inc – (NASDAQ:YI) by 64.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,659 shares of the company’s stock after purchasing an additional 2,605 shares during the quarter. Tower Research Capital LLC TRC’s holdings in 111 were worth $32,000 as of its most recent SEC filing. Institutional investors own 2.92% of the company’s stock.

111 Company Profile (NASDAQ:YI)

111, Inc, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers.

Further Reading: Initial Coin Offerings entail a high degree of risk

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.